Risk of Hematologic Malignancies in Patients With Acute Myocardial Infarction: A Nationwide Population-Based Cohort Study [0.03%]
急性心肌梗死患者发生血液系统恶性肿瘤的风险：全国人群基于的队列研究
Seug Yun Yoon,Mina Kim,Hoseob Kim et al.
Seug Yun Yoon et al.
Background: Acute myocardial infarction (AMI) and cancer are leading causes of death worldwide. However, the relationship between AMI and hematologic malignancies remains unclear. ...
Correlation of Natriuretic Peptides with Invasively Measured Intracardiac Filling Pressures in Patients With Cancer [0.03%]
癌症患者的利钠肽与侵入性测量的心腔充盈压之间的相关性分析
Mariya M Fatakdawala,Hyeon-Ju Ryoo Ali,Juhee Song et al.
Mariya M Fatakdawala et al.
Blood Pressure Lowering and Risk of Cancer: Individual Participant-Level Data Meta-Analysis and Mendelian Randomization Studies [0.03%]
降压与癌症风险：个体参与者数据的 meta 分析和孟德尔随机化研究
Milad Nazarzadeh,Emma Copland,Karl Smith Byrne et al.
Milad Nazarzadeh et al.
Background: Pharmacologic blood pressure (BP) lowering is typically a lifelong treatment, and both clinicians and patients may have concerns about the long-term use of antihypertensive agents and the risk for cancer. Howe...
Mitigation of Doxorubicin Cardiotoxicity With Synergistic miRNA Combinations Identified Using Combinatorial Genetics en masse (CombiGEM) [0.03%]
利用组合遗传筛选大规模识别协同microRNA组合以减轻多柔比星的心脏毒副作用
Yasutomi Higashikuni,Colin Platt,Margaret H Hastings et al.
Yasutomi Higashikuni et al.
Background: Cardiomyocyte loss occurs in acute and chronic cardiac injury, including cardiotoxicity due to chemotherapeutics like doxorubicin, and contributes to heart failure development. There is a pressing need for car...
Shared Mechanisms in Cancer and Cardiovascular Disease: S100A8/9 and the NLRP3 Inflammasome: JACC: CardioOncology State-of-the-Art Review [0.03%]
癌症和心血管疾病共有的机制：S100A8/9 和 NLRP3 炎症小体：JACC 心脏病学与肿瘤学前沿回顾
Sophie Van Linthout
Sophie Van Linthout
Inflammation and a dysregulated immune system are common denominators in cancer and cardiovascular disease (CVD). The Canakinumab Anti-Inflammatory Thrombosis Outcome Study (CANTOS) highlighted the convergence of interleukin (IL)-1β biolog...
Harlan M Krumholz,Biykem Bozkurt,Y Chandrashekhar et al.
Harlan M Krumholz et al.
Reply: Expanding Perspectives on Physical Activity and Cardiovascular Risk in Cancer Survivors [0.03%]
关于癌症幸存者体力活动和心血管风险的视角拓展的观点回应
Wonyoung Jung,Kyungdo Han,Dong Wook Shin
Wonyoung Jung
Expanding Perspectives on Physical Activity and Cardiovascular Risk in Cancer Survivors [0.03%]
扩展癌症幸存者身体活动和心血管风险的视角
Fan Zhang,Wenlong Yu,Mengchen Yin
Fan Zhang
Reply: Enalapril for Preventing Cardiotoxicity After High-Dose Anthracycline Therapy in Breast Cancer and Lymphoma Patients [0.03%]
依那普利预防乳腺癌和淋巴瘤高剂量化疗后的心脏毒性反应的疗效分析
David Austin,Rebecca H Maier,Chris Plummer
David Austin